215 related articles for article (PubMed ID: 15773956)
1. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
Gorlitzer M; Ankersmit J; Fiegl N; Meinhart J; Lanzenberger M; Unal K; Dunkler D; Kilo J; Wolner E; Grimm M; Grabenwoeger M
Transpl Int; 2005 Apr; 18(4):390-5. PubMed ID: 15773956
[TBL] [Abstract][Full Text] [Related]
2. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ
J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091
[TBL] [Abstract][Full Text] [Related]
3. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
[TBL] [Abstract][Full Text] [Related]
4. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
[TBL] [Abstract][Full Text] [Related]
5. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
[TBL] [Abstract][Full Text] [Related]
6. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
Goland S; Czer LS; Kass RM; De Robertis MA; Mirocha J; Coleman B; Capelli C; Raissi S; Cheng W; Fontana G; Trento A
J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
[TBL] [Abstract][Full Text] [Related]
7. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of pulmonary hypertension reversibility test with sodium nitroprusside in stratification of early death risk after orthotopic heart transplantation.
Zakliczynski M; Zebik T; Maruszewski M; Swierad M; Zembala M
Transplant Proc; 2005 Mar; 37(2):1346-8. PubMed ID: 15848716
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary hypertension and early mortality after orthotopic heart transplantation].
López-Ciudad VJ; López Pérez JM; Fojón Polanco S; Blanco Sierra FJ; Pradas Montilla G; Cuenca Castillo JJ; Vázquez González N; Hermida Alvarez LF
Rev Esp Cardiol; 1995 Aug; 48(8):552-6. PubMed ID: 7644809
[TBL] [Abstract][Full Text] [Related]
13. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
Chang PP; Longenecker JC; Wang NY; Baughman KL; Conte JV; Hare JM; Kasper EK
J Heart Lung Transplant; 2005 Aug; 24(8):998-1007. PubMed ID: 16102433
[TBL] [Abstract][Full Text] [Related]
14. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
Bourge RC; Kirklin JK; Naftel DC; White C; Mason DA; Epstein AE
J Thorac Cardiovasc Surg; 1991 Mar; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
[TBL] [Abstract][Full Text] [Related]
15. [Preoperative and intraoperative risk factors affecting mortality after heart transplantation: a single-center experience].
Güngör H; Ayık MF; Nalbantgil S; Ertugay S; Engin C; Yağdı T; Zoghi M; Ozbaran M
Anadolu Kardiyol Derg; 2011 Mar; 11(2):119-24. PubMed ID: 21285017
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with long-term survival following cardiac transplantation.
Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
[TBL] [Abstract][Full Text] [Related]
17. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
Liu MZ; Wang JH; Du J; Huang J; Li LH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates.
Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001
[TBL] [Abstract][Full Text] [Related]
19. Markers of pulmonary hypertension in potential candidates to heart transplantation.
Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
[TBL] [Abstract][Full Text] [Related]
20. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
